Sanj K Patel sold $14.3M of KNSA stock

Sanj K Patel, Chairman & CEO of Kiniksa Pharmaceuticals International, plc (KNSA), sold 151,300 shares of KNSA stock worth $14.3M, per an SEC Form 4 filed Nov 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 4, 2026, 2 days before it was made public.

KNSA has moved -2.4% since the trade date, from $96.12 to $93.86 (Nov 6, 2026 close).